Drug Shortage Report for PMS-IRBESARTAN-HCTZ

Last updated on 2023-04-06 History
Report ID 149254
Drug Identification Number 02328526
Brand name PMS-IRBESARTAN-HCTZ
Common or Proper name IRBESARTAN-HCTZ
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 12.5MG 300MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-14
Estimated end date 2023-04-01
Actual end date 2023-03-29
Shortage status Resolved
Updated date 2023-04-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2023-04-06 French Compare
v5 2023-04-06 English Compare
v4 2022-09-13 French Compare
v3 2022-09-13 English Compare
v2 2021-11-15 French Compare
v1 2021-11-15 English Compare

Showing 1 to 6 of 6